News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chronic Wounds Cost The Nation More Than $25 Billion Per Year, Reports Ron Najafi, CEO Of NovaBay Pharmaceuticals, Inc. (NBY)


4/29/2014 9:55:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, CEO of NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company, today reported on the tremendous medical toll from chronic wounds—and how the nation can reduce that toll. “Chronic wounds represent a major healthcare challenge,” he wrote in a new blog post. “According to a 2009 National Institutes of Health study, in the U.S. alone, 6.5 million patients suffered from chronic wounds with treatment costing in excess of $25 billion annually.”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES